| |
|
volgende >> |
|
uienkruid @ 24-05-2010 09:17:16 (http://www.ErikErik.com / CytRx Corporation) |
CytRx: All That Glitters Could Be Bright Gold (NASDAQ:CYTR) Print E-mail
6875
*
* 1
(5 votes, average 5.00 out of 5)
Written by Joseph Krueger
Today, CytRx Corporation (NASDAQ:CYTR) announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML). The positive opinion of the COMP has now been forwarded to the EU commission for final approval and publication in the community register. Bafetinib had previously been granted Orphan Drug Status for the treatment of Philadelphia chromosome-positive (Ph+) CML by the U.S. Food and Drug Administration (FDA).
This is a huge development for a small company. The response to this news did cause about a 10-15% spike in the stock price, but I feel this response was quite underwhelming and suggests that investors don’t really understand the implications of this development in the company. I think investors are missing the big picture with CYTR. In my article earlier this year about what biotech companies to look for (http://seekingalpha.com/article/182930-the-future-of-biotech-party-like-it-s-1999), I suggested that investors look for companies with drugs late in development (coming out of phase II or going into phase III). For these types of companies you can expect a large company to pay a small biotech company tens of millions of dollars up front with hundred of millions of continued milestone payments to support the studies; with royalties upon marketing of the drug. Today’s news about Array Biopharma’s (ARRY) partnership with Novartis (NVS) is just another example of what has been happening repeatedly this year. Soon enough, it should be CYTR’s turn for several reasons. |
|
uienkruid @ 10-05-2010 20:46:02 (http://www.ErikErik.com / CytRx Corporation) |
CYTR - CytRx Corporation
This is a stock that could be ready to explode any day, week or month.
The trend has been very weird with this stock. I have been watching this stock for a few months. Every single time it receives good news, it goes up about 20-30 cents and slowly sinks back down. It has received positive news about 5-8 times in the last 2 months. It has a strong resistance in the 80 cent range.
if you look at the trend:
CytRx Corporation - Google Finance
its coming to the low point and if the trend follows it will start to come back up. This is not a stock thats an overnighter. search the history of this company and you will see for yourself. It has been around for over 20 years, once trading for $38.50!!
Heres a quick bio from reuters
"CytRx Corporation (CytRx) is a biopharmaceutical research and development company engaged in the development of human therapeutics. The Company’s drug development pipeline includes two product candidates in clinical development for cancer indications, including registration studies of tamibarotene for the treatment of acute promyelocytic leukemia (APL). In addition to its core oncology programs, the Company is developing treatments for neurodegenerative and other disorders based on its small-molecule molecular chaperone amplification technology. The Company is also engaged in new-drug discovery research at its laboratory facility in San Diego, California, utilizing its master chaperone regulator assay (MaCRA) technology. Apart from its drug development programs and new-drug discovery research activities, the Company maintains a 45% equity interest in its former subsidiary, RXi Pharmaceuticals Corporation (RXi).
More from Reuters » "
Keep an eye out people, this could be big in a week or a months |
|
uienkruid @ 30-04-2010 21:42:45 (http://www.ErikErik.com / CytRx Corporation) |
|
volgende poging richting 1,60 |
|
uienkruid @ 22-03-2010 18:07:45 (http://www.ErikErik.com / CytRx Corporation) |
|
en hoge omzetten |
|
Bandit @ 22-03-2010 15:23:09 (http://www.ErikErik.com / CytRx Corporation) |
|
groeit goed |
|
uienkruid @ 19-03-2010 21:01:50 (http://www.ErikErik.com / CytRx Corporation) |
|
hopla 1,35 slot weer 11 % nog maar beginnetje |
|
Bandit @ 15-03-2010 23:11:42 (http://www.ErikErik.com / CytRx Corporation) |
5 producten in phase II
alleen jammer dat de omzet volgend jaar niet zo hoog uitvalt. Want volledig bedrag van ruim 20 miljoen dollar al binnen van deal.
Wel belang in rxii die het goed doet op de beurs de laatste weken / maanden.
Hopenlijk is dit begin van mooie uptrend |
|
uienkruid @ 15-03-2010 21:10:49 (http://www.ErikErik.com / CytRx Corporation) |
LOS ANGELES (AP) -- Biotechnology company CytRx Corp. said Monday its loss narrowed in 2009 as revenue increased and research and development costs fell.
The Los Angeles company, which specializes in oncology products, said it lost $4.8 million, or 5 cents per share, compared with a loss of $27.8 million, or 30 cents per share, in 2008. The company had fewer shares outstanding in 2008.
Revenue climbed 51 percent to $9.5 million. |
|
uienkruid @ 15-03-2010 21:09:44 (http://www.ErikErik.com / CytRx Corporation) |
|
+ 5% na de cijfers , rustig omhoog komende tijd |
|
uienkruid @ 11-03-2010 19:09:29 (http://www.ErikErik.com / CytRx Corporation) |
|
en gas er op , moet zeker naar 2 kunnen binnen paar weken |
|
uienkruid @ 23-02-2010 22:01:52 (http://www.ErikErik.com / CytRx Corporation) |
|
1.22 slot blijft prima liggen in dit sentiment,, alles wijst er op dat koers elk moment kan starten aan rit naar 1,60 |
|
uienkruid @ 04-02-2010 22:04:42 (http://www.ErikErik.com / CytRx Corporation) |
|
prima slot is wachten op de grote sprong maar met deze beurzen mag je blij wezen als je stukken niet zakken |
|
uienkruid @ 01-02-2010 22:03:55 (http://www.ErikErik.com / CytRx Corporation) |
|
hopla 1,24 slot , morgen 1,30++ |
|
uienkruid @ 26-01-2010 22:02:28 (http://www.ErikErik.com / CytRx Corporation) |
|
zo gap gedicht nu weer snel naar 1,46 a 1,60 |
|
uienkruid @ 21-01-2010 18:46:28 (http://www.ErikErik.com / CytRx Corporation) |
|
Our development strategy is to test these compounds in advanced-stage cancers, which could allow for rapid indications of efficacy, with the potential for data as early as the fourth quarter of this year. We believe these drug candidates could represent blockbuster opportunities for CytRx with potential revenue exceeding $2 billion." |
|
uienkruid @ 14-01-2010 19:00:35 (http://www.ErikErik.com / CytRx Corporation) |
|
RXII weer flink omhoog, volgende stap van cytr komt eraan richting de 1,60 |
|
epper77 @ 13-01-2010 23:55:23 (http://www.ErikErik.com / CytRx Corporation) |
|
of 2011, of 12... |
|
uienkruid @ 13-01-2010 22:11:14 (http://www.ErikErik.com / CytRx Corporation) |
|
voorlopig allerlei koopadviezen van niet de minste jongens..ze hebben 39% belang in RXII die ook bezig is aan een enorme stijging. kan wel eens de sensatie worden van 2010 |
|
epper77 @ 13-01-2010 22:10:41 (http://www.ErikErik.com / CytRx Corporation) |
|
tsja |
|
graaier @ 13-01-2010 22:08:27 (http://www.ErikErik.com / CytRx Corporation) |
|
ongeveer... |
|
graaier @ 13-01-2010 22:08:15 (http://www.ErikErik.com / CytRx Corporation) |
|
pharming ook... |
|
epper77 @ 13-01-2010 22:06:42 (http://www.ErikErik.com / CytRx Corporation) |
|
ze bestaan al wel 25 jaar |
|
robbie2 @ 13-01-2010 22:05:41 (http://www.ErikErik.com / CytRx Corporation) |
|
Ik begreep alleen Research and development, en California |
|
graaier @ 13-01-2010 22:02:52 (http://www.ErikErik.com / CytRx Corporation) |
zitten een hoop moeilijke termen in Robbie...
Alleen dat Orally kan ik een beetje plaatsen 
Heb ik vaker gehoord... ze proberen in te spelen op de gevoelens van de doorsnee beleggende man denk ik... |
|
epper77 @ 13-01-2010 21:56:52 (http://www.ErikErik.com / CytRx Corporation) |
|
maar goed, als je net die ene toptrader bent die begin 2009 instapte op 0,25 hebbie nu dikke plus |
| |
